Babesiosis
- B60.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM B60.0 became effective on October 1, 2023.
- This is the American ICD-10-CM version of B60.0 – other international versions of ICD-10 B60.0 may differ.
The following code(s) above B60.0 contain annotation back-references
that may be applicable to B60.0:
- A00-B99 Certain infectious and parasitic diseases
- B50-B64 Protozoal diseases
- B60 Other protozoal diseases, not elsewhere classified
Approximate Synonyms
- Babesia infection
- Hemolytic anemia due to babesiosis
- Hemolytic anemia, babesiosis
Clinical Information
- A group of tick-borne diseases of mammals including zoonoses in humans. They are caused by protozoa of the genus babesia, which parasitize erythrocytes, producing hemolysis. In the United States, the organism’s natural host is mice and transmission is by the deer tick ixodes scapularis.
- A parasitic infection caused by babesia. It is transmitted by ticks and infects the red blood cells. Signs and symptoms include fever, fatigue and hemolytic anemia.
- Tickborne disease caused by infection with protozoa; occurs in wild and domestic animals; in humans causes malaria-like symptoms, myalgia, nausea and splenomegaly; classic zoonotic disease.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): Deleted code
- 2021 (effective 10/1/2020): New code
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change